Cytomedix Inc Sample Contracts

AutoNDA by SimpleDocs
AMONG
Asset Purchase Agreement • January 17th, 2001 • Cytomedix Inc • Services-commercial physical & biological research • New York
Lease Page ----
Lease • May 15th, 2000 • Cytomedix Inc • Services-commercial physical & biological research
WITNESSETH:
Assignment and Assumption Agreement • January 17th, 2001 • Cytomedix Inc • Services-commercial physical & biological research • New York
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • September 21st, 2018 • Nuo Therapeutics, Inc. • Surgical & medical instruments & apparatus • Nevada

This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of September 17, 2018, by and between NUO THERAPEUTICS, INC., a Delaware corporation, with headquarters located at 207A Perry Parkway, Suite 1, Gaithersburg, MD 20877 (the “Company”), and AUCTUS FUND, LLC, a Delaware limited liability company, with its address at 545 Boylston Street, 2nd Floor, Boston, MA 02116 (the “Buyer”).

OF
Cytomedix Inc • March 29th, 2004 • Services-commercial physical & biological research • New York
ARTICLE 1 EFFECTIVE DATE AND TERM OF EMPLOYMENT
Employment Agreement • May 7th, 2004 • Cytomedix Inc • Services-commercial physical & biological research • Maryland
RECITALS
Termination Agreement • May 7th, 2004 • Cytomedix Inc • Services-commercial physical & biological research
OF
Cytomedix Inc • March 29th, 2004 • Services-commercial physical & biological research • New York
WITNESSETH:
Consulting Agreement • May 15th, 2000 • Cytomedix Inc • Services-commercial physical & biological research
ARTICLE 1
Employment Agreement • December 5th, 2002 • Cytomedix Inc • Services-commercial physical & biological research • California
RECITALS
Supply Agreement • January 17th, 2001 • Cytomedix Inc • Services-commercial physical & biological research • New York
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • February 20th, 2013 • Cytomedix Inc • Surgical & medical instruments & apparatus • Illinois

REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of February 18, 2013, by and between CYTOMEDIX, INC., a Delaware corporation, (the "Company"), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (together with it permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the "Purchase Agreement").

AutoNDA by SimpleDocs
COMMON STOCK PURCHASE WARRANT NUO THERAPEUTICS, INC.
Common Stock Purchase Warrant • November 20th, 2019 • Nuo Therapeutics, Inc. • Surgical & medical instruments & apparatus • Delaware

This COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the $[ ] senior secured promissory note to the Holder (as defined below) of even date) (the “Note”), [ ], (including any permitted and registered assigns, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from Nuo Therapeutics, Inc., a Delaware corporation (the “Company”), up to [ ] shares of Common Stock (as defined below) (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain note purchase agreement dated November 15, 2019, by and among the Company and the Holder (the “Purchase Agreement”).

OF
Cytomedix Inc • May 11th, 2004 • Services-commercial physical & biological research • New York
COMMON STOCK PURCHASE WARRANT CYTOMEDIX, INC.
Common Stock Purchase • October 8th, 2010 • Cytomedix Inc • Surgical & medical instruments & apparatus

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after April __, 2011, 180 days following the issuance date of this Warrant (the “Initial Exercise Date”) and on or prior to the close of business on the five (5) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Cytomedix, Inc., a Delaware corporation (the “Company”), up to ______ shares (the “Warrant Shares”) of Common Stock.

For the Purchase of Shares of Common Stock of
Cytomedix Inc • May 11th, 2004 • Services-commercial physical & biological research • Delaware
RECITALS
Royalty Agreement • January 17th, 2001 • Cytomedix Inc • Services-commercial physical & biological research • New York
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!